Skip to main content

UK Policing Agency Evaluating Epistem's DNA ID Technology

NEW YORK (GenomeWeb News) – UK biotech firm Epistem announced it is collaborating with a UK policing agency to evaluate the company's molecular diagnostics device for policing identification purposes.

Under the deal, Epistem and the National Policing Improvement Agency will evaluate the Genedrive device as part of the agency's Accelerated DNA Profiling Technology program. Specifically, NPIA plans to use the device "to target the amelogenin sex gene and other single tandem repeats that create the human DNA fingerprint."

The evaluation will last into 2012 and if successful other police agencies in the UK will also evaluate the device, Epistem said.

In addition to achieving quicker DNA identification, the technology reduces costs and improves efficiency, the company said. Depending on the results of its trial, Genedrive could be adopted by NPIA as a technology for rapid crime scene DNA analysis.

Genedrive is being positioned as a handheld device, and "brings a new point-of-need approach to disease diagnosis and identification" across a variety of purposes including pharmacogenomic uses in oncology, virology, and infectious disease detection, Epistem said. However, NPIA is evaluating the technology solely for policing purposes.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.